Previous 10 | Next 10 |
The Right is turning “nationalist,” the Left is turning “socialist,” and the US is foisting a trade war on the world which no one wants. Does that sound like the 1930s to you? Because it sounds like the 1930s to me. - A very unfunny joke I’ve been telli...
PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that Nikolai Sopko, MD, PhD, Chief Scientific Officer of PolarityTE, was selected to present at the annual Cell & Gene Meeting on the M...
Plus Therapeutics (NASDAQ: PSTV ) +99% on BARDA payment . More news on: Plus Therapeutics, Inc., Avadel Pharmaceuticals plc, Arotech Corporation, Stocks on the move, Read more ...
SkinTE, a novel human cellular and tissue-based product derived from a patient’s own skin, was used to treat a variety of skin defects that failed conventional treatments Limitations of current treatment options create need for new therapies to treat increasing incidence of f...
PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 in New York, NY. A live audio webcas...
- Final Data Readout of Pilot Trial Evaluating SkinTE for Treatment of Venous Stasis Leg Ulcers Designated Highest Scoring Poster Abstract in the Conference’s Case Series/Study Category - Four Poster Abstracts Will Be Presented Demonstrating Positive Clinical Outcomes of SkinTE...
SALT LAKE CITY , Sept. 9, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that an abstract with data from 15 patient cases where the Company's SkinTE!...
SALT LAKE CITY , Sept. 4, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the appointment of Peter Cohen , previously Lead Director, as Chairman of the B...
A Roller Coaster Ride So you say you want to invest in biotech? Data by YCharts PolarityTE ( PTE ) is a commercial-stage biotech in the regenerative medicine field, where until now there has been much more promise than results. If new management can execute they have an insane amount...
SALT LAKE CITY , Aug. 28, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the H.C. Wainwright 21st Annual Healthcare Conference on...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) Mississauga, ON - TheNewswire - M ay 30 , 202 3 - Pioneering Technology Corp. ( TSXV:PTE ) (“ Pioneering ” or the “ Company ”), a technology company and North America’s l...
(TheNewswire) Mississauga, ON – TheNewswire - May 5, 2023 - Pioneering Technology Corp. (“ Pioneering ” or the “ Company ”) (TSXV:PTE) , a technology company and North America's leader in cooking fire prevention technolo...
(TheNewswire) Mississauga, ON - TheNewswire - March 1, 2023 - Pioneering Technology Corp. ( TSXV:PTE ) (“ Pioneering ” or the “ Company ”), a technology company and North America’s leader in cooking fire prevention t...